Adrenocortical carcinoma manifesting pure primary aldosteronism: A case report and analysis of steroidogenic enzymes

Journal of Endocrinological Investigation

Volumn 23, Issue 2, 2000, Pages 112-117

  Yoshimoto, Takanobu ^a   Naruse, M ^a   Ito, Y ^a   Naruse, K ^a   Ueda, T ^b   Tanabe, A ^a   Harada, S ^a   Nishikawa, T ^a   Sasano, H ^c   Obara, T ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Yoshikawa Chuoh Hospital   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenocortical carcinoma; Aldosterone synthase; Hyperaldosteronism; Ribonuclease protection assay; Steroidogenic enzyme

Indexed keywords

3BETA HYDROXY DELTA5 STEROID DEHYDROGENASE; ALDOSTERONE; ALDOSTERONE SYNTHASE; CHOLESTEROL DERIVATIVE; CYTOCHROME P450; ENZYME; MESSENGER RNA;

ADRENAL CORTEX CARCINOMA; ADULT; ALDOSTERONE RELEASE; ARTICLE; CALCIFICATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPERTENSION; NUCLEOTIDE SEQUENCE; PRIMARY HYPERALDOSTERONISM;

EID: 0034076043     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343689     Document Type: Article

References (19)

1. Farge D., Chatellier G., Pagny J.Y. Isolated clinical syndrome of primary aldosteronism in four patients with adrenocortical carcinoma. Am. J. Med. 1987, 83: 635-640.
2. Greathouse D.J., McDermott M.T., Kidd G.S., Hofeldt F.D. Pure primary hyperaldosteronism due to adrenal cortical carcinoma. Am. J. Med. 1984, 76: 1132-1136.
3. Curnow K.M., Tusie-Luna M.-T., Pascoe L, Natarajan R., Gu J,-L, Nadler L.L., White P.C. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol. Endocrinol. 1991, 5: 1523-1525.
4. Sasano H. New approaches in human adrenocortical pathology: Assessment of adrenocortical function in surgical specimen of human adrenal glands. Endocrine Pathol. 1992, 3: 4-13.
5. 11β). J. Biol. Chem. 1989, 264: 20961-20967.
6. Sasano H. Suzuki T., Nagura H., Nishikawa T. Steroidogenesis in human adrenocortical carcinoma: biochemical activities, immunohistochemistry, and in situ hybridization of steroidogenic enzymes and histopathologic study in nine cases. Hum. Pathol. 1993, 24: 397-404.
7. Sasano H. Miyazaki S., Sawai T., Sasano N., Nagura H., Funahashi H., Aiba M., Demura H. Primary pigmented nodular adrenocortical disease (PP-NAD): immunohistochemical and in situ hybridization analysis of steroidogenic enzymes in eight cases. Modern Pathol. 1992, 5: 23-29.
8. Yoshimoto T., Naruse M., Naruse K., Fujimaki Y., Tanabe A. Muraki T., Itakura M., Hagiwara H., Hirose S., Demura H. Modulation of vascular natriuretic peptide receptor gene expression in hypertensive and obese hyperglycemic rats. Endocrinology 1995, 136: 2427-2434.
9. Kawamoto T., Mitsuuchi Y., Ohnishi T., Ichikawa Y., Yokoyama Y., Sumimoto H., Toda K., Miyahara K., Kuribayashi Y., Nakao K., Hosoda K., Yamamoto Y., Imura H., Shizuta Y. Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. Biochem. Biophys. Res. Commun. 1990, 173: 309-316.
10. Ogishima T., Shibata H., Shimada H., Mitani F., Suzuki H., Saruta T., Ishimura Y. Aldosterone synthase cytochrome P-450 expressed in the adrenals of patients with primary aldosteronism. J. Biol. Chem. 1991, 266: 10731-10734.
11. 131I-19-iodocholesterol. N. Engl. J. Med. 1971, 285: 1387-1393.
12. Barzon L., Scaroni C., Sonino N., Fallo F., Gregianin M., Macri C., Boscaro M. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J. Clin. Endocrinol. Metab. 1998, 83: 55-62.
13. 131I-19-iodocholesterol. N. Engl. J. Med. 1976, 294: 410-414.
14. 131I-19-iodocholesterol in the diagnostic evaluation of patients with aldosteronism. J. Clin. Endocrinol. Metabol. 1976, 42: 41-51.
15. 131I-6β-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans. J. Clin. Endocrinol. Metab. 1977, 45: 353-362.
16. Hoefnagels W.H., Claessens R.A., Corstens F.H., Drayer J.L., Kazem I., Kloppenborg P.W. Adrenal scintigraphy in primary aldosteronism. Improved visualization of the long-term pretreatment with dexamethasone. Nuklearmedizin 1981, 20: 76-81.
17. Conn J.W., Cohen E.L, Herwig K.R. The dexamethasone-modified adrenal scintiscan in primary aldosteronism (tumor versus hyperplasia). A comparison with adrenal venography and adrenal venous aldosterone. J. Lab. Clin. Med. 1976, 88: 841-856.
18. Sakashita S., Kashiwagi A., Aoki M., Ito Y., Chiba H., Kurosawa S., Inoue K., Koyanagi T. Primary aldosteronism due to adrenal cortical carcinoma. J. Urol. 1984, 132: 959-961.
19. Morioka M., Furukawa Y., Kobayashi T., Tanaka H., Ohashi Y., Jin T.X. Aldosterone-producing adrenal cortical cancer: a case report and analysis of steroidogenic enzymes in the tumor. Endocr. J. 1997, 44: 547-552.